194 related articles for article (PubMed ID: 29368067)
1. Cilostazol-Loaded Poly(ε-Caprolactone) Electrospun Drug Delivery System for Cardiovascular Applications.
Rychter M; Baranowska-Korczyc A; Milanowski B; Jarek M; Maciejewska BM; Coy EL; Lulek J
Pharm Res; 2018 Jan; 35(2):32. PubMed ID: 29368067
[TBL] [Abstract][Full Text] [Related]
2. Cilostazol-loaded electrospun three-dimensional systems for potential cardiovascular application: Effect of fibers hydrophilization on drug release, and cytocompatibility.
Rychter M; Milanowski B; Grześkowiak BF; Jarek M; Kempiński M; Coy EL; Borysiak S; Baranowska-Korczyc A; Lulek J
J Colloid Interface Sci; 2019 Feb; 536():310-327. PubMed ID: 30380431
[TBL] [Abstract][Full Text] [Related]
3. Long-lasting anti-platelet activity of cilostazol from poly(ε-caprolactone)-poly(ethylene glycol) blend nanocapsules.
Gomes MLS; da Silva Nascimento N; Borsato DM; Pretes AP; Nadal JM; Novatski A; Gomes RZ; Fernandes D; Farago PV; Zanin SMW
Mater Sci Eng C Mater Biol Appl; 2019 Jan; 94():694-702. PubMed ID: 30423756
[TBL] [Abstract][Full Text] [Related]
4. Electrospun poly(lactic acid) (PLA)/poly(butylene adipate-co-terephthalate) (PBAT) nanofibers for the controlled release of cilostazol.
Antunes LR; Breitenbach GL; Pellá MCG; Caetano J; Dragunski DC
Int J Biol Macromol; 2021 Jul; 182():333-342. PubMed ID: 33798589
[TBL] [Abstract][Full Text] [Related]
5. Fabrication of doxycycline-loaded electrospun PCL/PEO membranes for a potential drug delivery system.
Eskitoros-Togay ŞM; Bulbul YE; Tort S; Demirtaş Korkmaz F; Acartürk F; Dilsiz N
Int J Pharm; 2019 Jun; 565():83-94. PubMed ID: 31063838
[TBL] [Abstract][Full Text] [Related]
6. Ocular biocompatibility of dexamethasone acetate loaded poly(ɛ-caprolactone) nanofibers.
Da Silva GR; Lima TH; Fernandes-Cunha GM; Oréfice RL; Da Silva-Cunha A; Zhao M; Behar-Cohen F
Eur J Pharm Biopharm; 2019 Sep; 142():20-30. PubMed ID: 31129274
[TBL] [Abstract][Full Text] [Related]
7. Star poly(ε-caprolactone)-based electrospun fibers as biocompatible scaffold for doxorubicin with prolonged drug release activity.
Bala Balakrishnan P; Gardella L; Forouharshad M; Pellegrino T; Monticelli O
Colloids Surf B Biointerfaces; 2018 Jan; 161():488-496. PubMed ID: 29128835
[TBL] [Abstract][Full Text] [Related]
8. Ofloxacin Loaded Electrospun Fibers for Ocular Drug Delivery: Effect of Formulation Variables on Fiber Morphology and Drug Release.
Karataş A; Algan AH; Pekel-Bayramgil N; Turhan F; Altanlar N
Curr Drug Deliv; 2016; 13(3):433-43. PubMed ID: 26521656
[TBL] [Abstract][Full Text] [Related]
9. Double controlled release of highly insoluble cilostazol using surfactant-driven pH dependent and pH-independent polymeric blends and in vivo bioavailability in beagle dogs.
Nam KY; Cho SM; Choi YW; Park C; Meghani NM; Park JB; Lee BJ
Int J Pharm; 2019 Mar; 558():284-290. PubMed ID: 30641181
[TBL] [Abstract][Full Text] [Related]
10. Aspirin-loaded electrospun poly(ε-caprolactone) tubular scaffolds: potential small-diameter vascular grafts for thrombosis prevention.
Del Gaudio C; Ercolani E; Galloni P; Santilli F; Baiguera S; Polizzi L; Bianco A
J Mater Sci Mater Med; 2013 Feb; 24(2):523-32. PubMed ID: 23135411
[TBL] [Abstract][Full Text] [Related]
11. Electrospun curcumin loaded poly(ε-caprolactone)/gum tragacanth nanofibers for biomedical application.
Ranjbar-Mohammadi M; Bahrami SH
Int J Biol Macromol; 2016 Mar; 84():448-56. PubMed ID: 26706845
[TBL] [Abstract][Full Text] [Related]
12. Investigation of Molecular Weight, Polymer Concentration and Process Parameters Factors on the Sustained Release of the Anti-Multiple-Sclerosis Agent Teriflunomide from Poly(
Bikiaris ND; Koumentakou I; Michailidou G; Kostoglou M; Vlachou M; Barmpalexis P; Karavas E; Papageorgiou GZ
Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015319
[TBL] [Abstract][Full Text] [Related]
13. A systematic study of captopril-loaded polyester fiber mats prepared by electrospinning.
Zhang H; Lou S; Williams GR; Branford-White C; Nie H; Quan J; Zhu LM
Int J Pharm; 2012 Dec; 439(1-2):100-8. PubMed ID: 23043960
[TBL] [Abstract][Full Text] [Related]
14. Cefazolin-loaded polycaprolactone fibers produced via different electrospinning methods: Characterization, drug release and antibacterial effect.
Radisavljevic A; Stojanovic DB; Perisic S; Djokic V; Radojevic V; Rajilic-Stojanovic M; Uskokovic PS
Eur J Pharm Sci; 2018 Nov; 124():26-36. PubMed ID: 30130639
[TBL] [Abstract][Full Text] [Related]
15. Magnesium oxide nanoparticle-loaded polycaprolactone composite electrospun fiber scaffolds for bone-soft tissue engineering applications: in-vitro and in-vivo evaluation.
Suryavanshi A; Khanna K; Sindhu KR; Bellare J; Srivastava R
Biomed Mater; 2017 Sep; 12(5):055011. PubMed ID: 28944766
[TBL] [Abstract][Full Text] [Related]
16. Melt electrospinning vs. solution electrospinning: A comparative study of drug-loaded poly (ε-caprolactone) fibres.
Lian H; Meng Z
Mater Sci Eng C Mater Biol Appl; 2017 May; 74():117-123. PubMed ID: 28254275
[TBL] [Abstract][Full Text] [Related]
17. Step-by-step design of poly (ε-caprolactone) /chitosan/Melilotus officinalis extract electrospun nanofibers for wound dressing applications.
Shahrousvand M; Haddadi-Asl V; Shahrousvand M
Int J Biol Macromol; 2021 Jun; 180():36-50. PubMed ID: 33727184
[TBL] [Abstract][Full Text] [Related]
18. Curcumin-loaded electrospun polycaprolactone/montmorillonite nanocomposite: wound dressing application with anti-bacterial and low cell toxicity properties.
Sadeghianmaryan A; Yazdanpanah Z; Soltani YA; Sardroud HA; Nasirtabrizi MH; Chen X
J Biomater Sci Polym Ed; 2020 Feb; 31(2):169-187. PubMed ID: 31609684
[TBL] [Abstract][Full Text] [Related]
19. Porous silicon-poly(ε-caprolactone) film composites: evaluation of drug release and degradation behavior.
Bodiford NK; McInnes SJP; Voelcker NH; Coffer JL
Biomed Microdevices; 2018 Aug; 20(3):71. PubMed ID: 30097808
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and characterization of CaO-loaded electrospun matrices for bone tissue engineering.
Münchow EA; Pankajakshan D; Albuquerque MT; Kamocki K; Piva E; Gregory RL; Bottino MC
Clin Oral Investig; 2016 Nov; 20(8):1921-1933. PubMed ID: 26612403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
